WAHRHAFTIG DAVID I

David I. Wahrhaftig is a private-equity executive and managing director at Kelso & Company who has served as a corporate director across several public companies. SEC filings list him as a director or significant reporting person for firms such as Endo (Endo Health Solutions/Endo Pharmaceuticals), Earle M. Jorgensen Company, BWAY Corporation, FairPoint Communications, and Waste Services.^[1]

Career Background

• Managing director at Kelso & Company, a private equity firm; has been with Kelso since the late 1980s and a managing director since the 1990s.^[1]
• Director of Endo (Endo Pharmaceuticals / Endo Health Solutions), as documented in company proxy and SEC filings.^[2]
• Director of Earle M. Jorgensen Company, identified in company and SEC disclosure materials.^[3]
• Served on BWAY Corporation’s board as a director, as described in the company’s SEC filings and proxy materials.^[4]

Current Positions

• Managing Director, Kelso & Company (private equity).^[1]
• Director — Endo Health Solutions / Endo Pharmaceuticals (ticker historically ENDP).^[2]
• Director — BWAY Corporation (ticker BWY / related filings).^[4]
• Reporting person or director relationships with FairPoint Communications (ticker FRP) and Waste Services, Inc. (ticker WSII) are reflected in SEC filings and Form 3/4 disclosures.^[5]

SEC Filing Context

• SEC records show multiple Section 16 filings (Form 3/4) under his reporting name and Kelso-related reporting groups, reflecting longstanding board and ownership reporting responsibilities.^[6]
• Filings across the cited companies identify him as a director and/or a reporting person associated with Kelso investment entities, consistent with routine director and insider reporting practices.^[3]